Eric Benevich
Corporate Officer/Principal chez NEUROCRINE BIOSCIENCES, INC.
Fortune : 6 M $ au 31/03/2024
Postes actifs de Eric Benevich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2015 | - |
Historique de carrière de Eric Benevich
Anciens postes connus de Eric Benevich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVANIR PHARMACEUTICALS INC | Public Communications Contact | 01/07/2005 | 01/01/2015 |
| Sales & Marketing | 30/12/2011 | 01/01/2015 | |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Sales & Marketing | - | - |
Formation de Eric Benevich
| Washington State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Sales & Marketing | 2 |
| Public Communications Contact | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Commercial Services |
- Bourse
- Insiders
- Eric Benevich
- Expérience
